Advertisement
Advertisement
U.S. markets open in 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

ESSA Pharma Inc. (EPIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.0000+0.0200 (+0.67%)
At close: 04:00PM EDT
3.0500 +0.05 (+1.67%)
After hours: 05:12PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • C
    Chris
    FDA gives Fast-Track Designation to Epi-7386, Essa's lead molecule for treating castrate-resistant prostate cancer.

    So development will be faster and cheaper - less bureaucratically onerous.

    The FDA must have been impressed by the pre-clinical data they've seen and, of course, Epi-7386 would meet a major unmet need, if it proves to be effective.
  • L
    Liam
    Invested a ton into it, expect it to go to 50+, already went up over 10% today, and have even done 20%+ 2 times in the last month. Gonna definitly go up.
  • H
    HSL
    This stock has incredible upside potential. If the clinical trials follow the success of the animal research, the analysts are looking at a value of $32 to $60, even before takeover interest, which could propel Epix well over $100. The recent price drops have no import. So staying long, even buying more.
    Bullish
  • M
    Manuel
    $20 soon here folks
  • A
    Alex K
    Great gains today
  • C
    Chris
    The public offering of $130 million in EPIX stock was successfully completed at a price of $27.

    The underwriter of the offer has an option to purchase 724,637 more shares.

    This major fund-raising, at a high share price reflecting the continuing positive clinical and corporate news, puts them in a very strong financial position to carry forward research over the next few years.
  • k
    kit
    made a little coin over past week not bad
  • H
    HSL
    If prostate cancer treatment trials work, this stock could go back to its 2015 levels of $235.
    Bullish
  • H
    HSL
    Great, unexpected news for Phase 1 success! Who knows, maybe after Phase II & III success, Epix can get back to its all time high in July, 2015 of $235!!
  • 3
    357Sig
    Bought some around 9 months ago, then maybe around 5-6 months ago. I think this pushed to $40 soon, so may buy some more again. Need to research the timing of clinical trials.
  • k
    kit
    glad a grabbed a few a week back. not bad me likes the action
  • L
    Letty F
    So this one don't have any Holder not even the company and the price keep going up while stock with big investors going down the drain, I guess that's the secret if no wall street investors nobody manipulates the price.
  • T
    Terminal Gravity
    $ERYP conversation
    Are we getting options? If so, a really good thing...

    Hyacinth Markets
    @63_hyacinth

    new option listings and three option delistings on August 25th
    $BGSF $BSN $CXDO $EDUT $EPIX $ERYP $FKWL $HBB $HFFG $IMCC $INVO $ISSC $ITOS $KXIN $LNSR $LYEL $NMTC $RKLB $SMRT $VEV $XGN $ZEST $AJAX $FWAA $VACQ
    Bullish
  • S
    Sean
    Just got a large position here. Expecting great news soon.
  • T
    TheKid
    I really really really like that Blackstone continues to own shares and is upping the ante with continued board representation!!
  • T
    TheKid
    This is going higher and higher..Is anybody listening?
    Bullish
  • A
    Arthur
    I bought 10,000
  • D
    DUFF M
    Anyone out there? Any thoughts on Epix?
  • 3
    357Sig
    Initiated a new position here. Will add over time.
Advertisement
Advertisement